WallStreetZenWallStreetZen

NASDAQ: VCYT
Veracyte Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Veracyte revenue was $463.39M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $114.5M, down 3.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VCYT annual revenue was $445.8M, with 23.5% growth year-over-year.

VCYT past revenue growth

How has VCYT's revenue growth performed historically?

Company
23.42%
Industry
150.55%
Market
20.46%
VCYT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VCYT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VCYT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VCYT revenue history

Current Revenue
$463.4M
Current Earnings
$33.0M
Current Profit Margin
7.1%

Be the first to know when VCYT announces revenue.

VCYT Revenue History By Year

VCYT Yearly RevenueVCYT RevenueVCYT ChangeVCYT Revenue Growth
2024-12-31$445.76M$84.71M+23.46%
2023-12-31$361.05M$64.52M+21.76%
2022-12-31$296.54M$77.02M+35.09%
2021-12-31$219.51M$102.03M+86.85%
2020-12-31$117.48M-$2.89M-2.40%
2019-12-31$120.37M$28.36M+30.82%
2018-12-31$92.01M$20.06M+27.87%
2017-12-31$71.95M$6.87M+10.55%
2016-12-31$65.09M$15.58M+31.48%
2015-12-31$49.50M$11.31M+29.62%
2014-12-31$38.19M$16.31M+74.51%
2013-12-31$21.88M$10.26M+88.20%
2012-12-31$11.63M$8.98M+339.62%
2011-12-31$2.65MN/AN/A

1 of 1

Veracyte Revenue FAQ

What was VCYT's revenue last quarter?

On Invalid Date, Veracyte (NASDAQ: VCYT) reported Q1 2025 revenue of $114.47 million up 18.2% year over year. In the same quarter last year, Veracyte's revenue was $96.84 million.

What was Veracyte's revenue in 2024?

Veracyte's annual revenue for the twelve months ending Dec 31, 2024 was $445.76 million, a 23.46% increase year over year.

How much does Veracyte make in a day?

Based on Veracyte annual revenue for the past five years, VCYT makes an average of $789,231.78 per day.

What was Veracyte's annual revenue growth in the past year?

As of Q4 2025, Veracyte's revenue has grown 23.42% year over year. This is 127.13 percentage points lower than the US Biotechnology industry revenue growth rate of 150.55%. Veracyte's revenue in the past year totaled $463.39 million.

How much does Veracyte make in a year?

Veracyte's revenue by year for the past five years is:
  • Veracyte's revenue for the twelve months ending Dec 31, 2024 was $445.76 million, a 23.46% increase year over year.
  • Veracyte's annual revenue for Dec 31, 2023 was $361.05 million, a 21.76% increase from 2022.
  • Veracyte's annual revenue for 2022 was $296.54 million, a 35.09% increase from 2021.
  • Veracyte's annual revenue for 2021 was $219.51 million, a 86.85% increase from 2020.
  • Veracyte's annual revenue for 2020 was $117.48 million, a 2.4% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.